LAUCK ANDREW

SEC Form 4 insider trading activity

LAUCK ANDREW has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Aug 3, 2026.

On the most recent filing, LAUCK ANDREW is listed as Director at Strata Critical Medical, Inc. Inside the rolling window, LAUCK ANDREW reported 1 open-market purchase totaling $22K in SRTA and no open-market sales.

Companies traded

Other insiders at SRTA

Insider Buying

$22K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
SRTA
LAUCK ANDREW
Purchase$22KDec 5SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has LAUCK ANDREW made?

LAUCK ANDREW has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.

Which companies does LAUCK ANDREW trade?

LAUCK ANDREW has filed SEC Form 4 disclosures for 1 company, including SRTA.

When was LAUCK ANDREW's most recent SEC Form 4 filing?

LAUCK ANDREW's most recent SEC Form 4 filing on Tracefour is dated Aug 3, 2026.

What is LAUCK ANDREW's total buy and sell value in the current window?

Inside the rolling retention window, LAUCK ANDREW bought $22K and sold $0 based on SEC Form 4 filings.

What was LAUCK ANDREW's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 5,000 SRTA shares on 2025-12-05, worth $22K, per SEC Form 4 filings.